Trials / Withdrawn
WithdrawnNCT01569282
Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer
Double Bypass vs Stent Strategy in Peroperatively Diagnosed Irresectable Pancreatic Cancer - A Prospective Randomized Multicenter Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Göteborg University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Double bypass (hepaticojejunostomy + gastrojejunostomy) is compared to stent strategy in patients planned for curative pancreatic resection in whom peroperative findings makes resection impossible.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Hepaticojejunostomy and gastroenterostomy | Standard surgical techniques |
| PROCEDURE | Stent strategy | Biliary and/or enteral stents on demand |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2015-04-30
- Completion
- 2015-10-31
- First posted
- 2012-04-03
- Last updated
- 2019-03-22
Locations
6 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01569282. Inclusion in this directory is not an endorsement.